2026-526359-75-00RecruitingPhase 4
A Rollover Study to Follow the Long-term Durability of Response to UGN-103 in Participants With Recurrent Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer (LG-IR-NMIBC) From Study BL013
A Rollover Study to Follow the Long-term Durability of Response to UGN-103 in Participants From Study BL013
Source: EU CTIS (euclinicaltrials.eu) · Last updated 15 Sept 2026
Brief summary (registry, in English)
Collect long-term durability of response data from participants with an ongoing complete response to UGN-103 at the end of Study BL013
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 33 (estimated)
- First submitted
- 29 May 2026
- Start date
- 6 Oct 2026
- Lead sponsor
- Urogen Pharma Ltd.
- Diseases
- Bladder cancer
- EU CT number
- 2026-526359-75-00
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 33
- 12 sites in 5 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Other
- Participant has not provided written informed consent for the rollover protocol.
- 2.Participant did not complete Study BL013 with an ongoing CR
Who the study is looking for
- Participant has provided written informed consent for the rollover study.
- Participant completed Study BL013 with an ongoing CR
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (12)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Multiprofile Hospital For Active Treatment "Dr. Tota Venkova" AD Coordinator of this site? Confirm its status | Gabrovo | Bulgaria | Recruiting |
| Multiprofile Hospital For Active Treatment - Shumen AD Coordinator of this site? Confirm its status | Shumen | Bulgaria | Recruiting |
| University Multiprofile Hospital For Active Treatment And Emergency Medicine N I Pirogov Coordinator of this site? Confirm its status | Sofiya | Bulgaria | Recruiting |
| Laane-Tallinna Keskhaigla AS Coordinator of this site? Confirm its status | Pohja-Tallinna Linnaosa | Estonia | Recruiting |
| Tartu University Hospital Coordinator of this site? Confirm its status | Tartu Linn | Estonia | Recruiting |
| Hospital Universitario La Paz Coordinator of this site? Confirm its status | Madrid | Spain | Recruiting |
| Daugavpils regionala slimnica SIA Coordinator of this site? Confirm its status | Daugavpils | Latvia | Recruiting |
| Liepajas Regionala Slimnica SIA Coordinator of this site? Confirm its status | Liepaja | Latvia | Recruiting |
| Rigas Austrumu kliniska universitates slimnica SIA Coordinator of this site? Confirm its status | Riga | Latvia | Recruiting |
| Pauls Stradins Clinical University Hospital Coordinator of this site? Confirm its status | Riga | Latvia | Recruiting |
| Spitalul Clinic Judetean de Urgenta Brasov Coordinator of this site? Confirm its status | Brasov | Romania | Not yet recruiting |
| Spitalul Clinic Colentina Bucuresti Coordinator of this site? Confirm its status | Bucharest | Romania | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.